Benjamin R Griffin1, J Pedro Teixeira2, Sophia Ambruso1, Michael Bronsert3, Jay D Pal4, Joseph C Cleveland4, T Brett Reece4, David A Fullerton4, Sarah Faubel5, Muhammad Aftab6. 1. Division of Nephrology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colo. 2. Division of Critical Care, Department of Medicine, Washington University, St Louis, Mo. 3. Adult and Child Consortium for Health Outcomes Research and Delivery Science and Surgical Outcomes and Applied Research, University of Colorado, Aurora, Colo. 4. Division of Cardiothoracic Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, Colo; Rocky Mountain Regional VA Medical Center, Aurora, Colo. 5. Division of Nephrology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colo; Rocky Mountain Regional VA Medical Center, Aurora, Colo. 6. Division of Cardiothoracic Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, Colo; Rocky Mountain Regional VA Medical Center, Aurora, Colo. Electronic address: muhammad.aftab@cuanschutz.edu.
Abstract
OBJECTIVES: Severe acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality. METHODS: In this retrospective propensity score-matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS). RESULTS: Stage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71-3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45). CONCLUSIONS: Stage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity.
OBJECTIVES: Severe acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality. METHODS: In this retrospective propensity score-matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS). RESULTS: Stage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71-3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45). CONCLUSIONS: Stage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity.
Authors: Gorav Ailawadi; Helena L Chang; Patrick T O'Gara; Karen O'Sullivan; Y Joseph Woo; Joseph J DeRose; Michael K Parides; Vinod H Thourani; Sophie Robichaud; A Marc Gillinov; Wendy C Taddei-Peters; Marissa A Miller; Louis P Perrault; Robert L Smith; Lyn Goldsmith; Keith A Horvath; Kristen Doud; Kim Baio; Annetine C Gelijns; Alan J Moskowitz; Emilia Bagiella; John H Alexander; Alexander Iribarne Journal: J Thorac Cardiovasc Surg Date: 2017-02-09 Impact factor: 5.209
Authors: Martin Matejovic; Jiri Chvojka; Jaroslav Radej; Lenka Ledvinova; Thomas Karvunidis; Ales Krouzecky; Ivan Novak Journal: Contrib Nephrol Date: 2011-09-09 Impact factor: 1.580
Authors: Megan SooHoo; Benjamin Griffin; Anna Jovanovich; Danielle E Soranno; Emily Mack; Sonali S Patel; Sarah Faubel; Katja M Gist Journal: Pediatr Nephrol Date: 2018-03-05 Impact factor: 3.714
Authors: G Zanardo; P Michielon; A Paccagnella; P Rosi; M Caló; V Salandin; A Da Ros; F Michieletto; G Simini Journal: J Thorac Cardiovasc Surg Date: 1994-06 Impact factor: 5.209
Authors: Ephraim L Tsalik; Laurel K Willig; Brandon J Rice; Jennifer C van Velkinburgh; Robert P Mohney; Jonathan E McDunn; Darrell L Dinwiddie; Neil A Miller; Eric S Mayer; Seth W Glickman; Anja K Jaehne; Robert H Glew; Mohan L Sopori; Ronny M Otero; Kevin S Harrod; Charles B Cairns; Vance G Fowler; Emanuel P Rivers; Christopher W Woods; Stephen F Kingsmore; Raymond J Langley Journal: Kidney Int Date: 2015-05-20 Impact factor: 10.612
Authors: Chetna K Pande; Mallory B Smith; Danielle E Soranno; Katja M Gist; Dana Y Fuhrman; Kristin Dolan; Andrea L Conroy; Ayse Akcan-Arikan Journal: Front Pediatr Date: 2022-06-30 Impact factor: 3.569
Authors: Benjamin R Griffin; Chaorong Wu; John C O'Horo; Sarah Faubel; Diana Jalal; Kianoush Kashani Journal: Crit Care Med Date: 2021-02-01 Impact factor: 7.598
Authors: Benjamin R Griffin; Michael Bronsert; T Brett Reece; Jay D Pal; Joseph C Cleveland; David A Fullerton; Sarah Faubel; Muhammad Aftab Journal: J Thorac Cardiovasc Surg Date: 2020-06-26 Impact factor: 5.209